Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;24(1):9–14. doi: 10.1002/clc.4960240103

Which fasting triglyceride levels best reflect coronary risk? evidence from the turkish adult risk factor study

Altan Onat 1,✉, Vedat Sansoy 2, Beytullah Yildirim 3
PMCID: PMC6655240  PMID: 11195622

Abstract

Background: Association between raised low‐density lipoprotein cholesterol (LDL‐C) levels and high risk for coronary heart disease (CHD) is well established and taken into account in guidelines on coronary prevention.

Hypothesis: The relationship between risk for coronary heart disease (CHD) and the levels of fasting plasma triglycerides was studied in the cohort of the Turkish Adult Risk Factor Study, a representative random sample of an adult population.

Methods: In 829 men and 907 women aged ≥ 27 years (mean 48.5 ± 11), plasma lipids and lipoproteins were measured by the enzymatic dry method in the postabsorptive state. A sample of values was validated in a reference laboratory. Apoliprotein (apo) A‐I and B were measured by the turbidimetric immunoassay using commercial kits in part of the cohort. Blood pressure and anthropometric measurements were made. Criteria for the diagnosis of CHD were based on history, cardiovascular examination, and Minnesota coding of resting electrocardiograms.Coronary heart disease was diagnosed in about 7% of the subjects. Participants were divided into four categories depending on their triglyceride levels: I = < 100 mg/dl (282 men, 400 women), II = 100–139 mg/dl (204 men, 228 women), III = 140–212 mg/dl (188 men, 180 women), and IV = ≥ 212 mg/dl (155 men, 99 women).

Results: After adjustment for age, high‐density lipoprotein (HDL) and low‐density lipoprotein (LDL) cholesterol, smoking, and body mass index by logistic regression analysis, and after assigning the CHD risk of 1 to Category I, the relative risk for men and women combined rose to 1.42 in Category III (p<0.045) while it diminished to 0.94 in Category IV (p = 0.79). In women, the odds ratio (OR) rose gradually up to 1.78 (p < 0.025) in Category III, only to decline in Category IV. The OR in men was slightly, insignificantly, and equally elevated in Categories III and IV. Patients with CHD in Category III were not distinguished from those in Category IV by the studied risk parameters. It was suggested that high risk for CHD—particularly in subjects with slightly elevated or normal cholesterol levels—is often not reflected by extreme increases of fasting triglycerides but best by modest elevations (140–212 mg/dl), which serve better as a marker of triglyceride‐rich lipoprotein particles. This knowledge may prove to be of value in population screening and individual risk assessment.

Keywords: coronary risk, epidemiology, plasma lipids, risk factors, triglycerides

Full Text

The Full Text of this article is available as a PDF (595.5 KB).

References

  • 1. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F: Triglyceride concentration and ischemic heart disease: An eight‐year follow‐up in the Copenhagen Male Study. Circulation 1998; 97: 1029–1036 [DOI] [PubMed] [Google Scholar]
  • 2. Egger M, Davey Smith G, Pflüger D, Altpeter E, Elwood PC: Triglycerides as a risk factor for ischaemic heart disease in British men: Effect of adjusting for measurement error. Atherosclerosis 1999; 143: 275–284 [DOI] [PubMed] [Google Scholar]
  • 3. Genest JJ, McNamara JR, Ordovas JM, Jenner JL, Silberman SR, Anderson KM, Wilson PWF, Salem DN, Schaefer EJ: Lipoprotein cholesterol, apolipoprotein A‐I and B and lipoprotein(a) abnormality in men with premature coronary heart disease. J Am Coll Cardiol 1992; 19: 792–802 [DOI] [PubMed] [Google Scholar]
  • 4. Onat A, şurdum‐Avci G, şenocak M, Örnek E, Gözükara Y: Plasma lipids and their interrelationship in Turkish adults. J Epidemol Commun Health 1992; 46: 470–476 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després J‐P: Small, dense low‐density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation 1997; 95: 69–75 [DOI] [PubMed] [Google Scholar]
  • 6. Onat A, şenocak Mş: Relative risk of factors for coronary heart disease in population with low cholesterol levels. Int J Cardiol 1994; 43: 51–60 [DOI] [PubMed] [Google Scholar]
  • 7. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499–502 [PubMed] [Google Scholar]
  • 8. Rose GA, Blackburn H, Gillum RF, Prineas RJ: Cardiovascular Survey Methods, 2nd ed., p. 124–127. Geneva: WHO, 1982. [Google Scholar]
  • 9. Dawson‐Saunders B, Trapp RG. (Eds.): Basic and Clinical Biostatistics, 2nd ed., p. 134–136. London: Prentice‐Hall Int. Inc., 1994. [Google Scholar]
  • 10. Wood D, DeBacker G, Faergeman O, Graham I, Mancia G, Pyörala K, and members of the Task Force : Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other societies on coronary prevention. Eur Heart J 1998; 19: 1434–1503 [DOI] [PubMed] [Google Scholar]
  • 11. Schonfeld G: Inherited disorders of lipid transport. Endocrinol Metab Clin North Am 1990; 19: 229–257 [PubMed] [Google Scholar]
  • 12. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM: Low density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988; 260: 1917–1921 [PubMed] [Google Scholar]
  • 13. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ: Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992; 12: 187–195 [DOI] [PubMed] [Google Scholar]
  • 14. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994; 106: 241–253 [DOI] [PubMed] [Google Scholar]
  • 15. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PM, Schneider AE, Hales CN, Yudkin JS: The relationships of concentrations of insulin, intact proinsulin and 32–33 split proinsulin with cardiovascular risk factors in type 2 (non‐insulin‐dependent) diabetic subjects. Diabetologia 1990; 33: 532–537 [DOI] [PubMed] [Google Scholar]
  • 16. Nordestgaard BG, Lewis B: Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain. Atherosclerosis 1991; 87: 39–46 [DOI] [PubMed] [Google Scholar]
  • 17. Mack WJ, Krauss R, Hodis HN: Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS): Treatment effects and relation to coronary angiographic progression. Arterioscler Thromb Vasc Biol 1996; 16: 697–704 [DOI] [PubMed] [Google Scholar]
  • 18. Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, Hemphill LC, Kramsch DM, Blankenhorn DH: Triglycerideand cholesterol‐rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 1994; 90: 42–49 [DOI] [PubMed] [Google Scholar]
  • 19. Swinkels DW, Demacker PNM, Hendricks JCM, van't Laar A: Low density lipoprotein subtractions and relationship to other risk factors coronary artery disease in healthy individuals. Arteriosclerosis 1989; 9: 604–613 [DOI] [PubMed] [Google Scholar]
  • 20. Coresh J, Kwiterovich PO, Smith HH, Bachorik PS: Association of plasma triglyceride and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993; 34: 1687–1697 [PubMed] [Google Scholar]
  • 21. Lahdenpera S, Tilly‐Kiesi M, Vuorinen‐Markkola H, Kuusi T, Taskinen MR: Effect of gemfibrozil on low‐density lipoprotein particle size, density distribution, and composition in patients with type II diabetes. Diabetes Care 1993; 313: 1557–1563 [DOI] [PubMed] [Google Scholar]
  • 22. Mehta J, Mehta P, Lawson D, Saldeen T: Plasma tissue plasminogen activation inhibitor levels in coronary heart disease: Correlation with age and serum triglyceride concentrations. J Am Coll Cardiol 1987; 9: 263–268 [DOI] [PubMed] [Google Scholar]
  • 23. Onat A, Dursunoǧlu D, Sansoy V: Relatively high coronary death and event rates in Turkish women: Relation to three major risk factors in five‐year follow‐up of cohort. Int J Cardiol 1997; 61: 69–77 [DOI] [PubMed] [Google Scholar]
  • 24. Stavenow L, Kjellström T: Influence of serum triglyceride levels on the risk for myocardial infarction in 12,510 middle aged males: Interaction with serum cholesterol. Atherosclerosis 1999; 147: 243–247 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES